Effect of low-dose local anesthetics on tyrosine kinase activity of growth factor receptors
Effect of low-dose local anesthetics on tyrosine kinase activity of growth factor receptors
批准号:
14571459
负责人:
HIROSE Munetaka
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
局麻药通过直接作用于失活门抑制钠通道。首席研究员发现受体型酪氨酸激酶激活环自磷酸化位点周围的氨基酸序列与钠通道失活门周围的氨基酸序列惊人地相似,并开始研究局麻药对受体型酪氨酸激酶的影响。根据我们的假设,局部麻醉药,一种具有芳香环的胺,会通过静电、π-π堆叠、阳离子-π和C-H-π相互作用与芳香、酸性或碱性氨基酸相互作用,我们研究了利多卡因对受体型酪氨酸激酶的自磷酸化的影响,如表皮生长因子受体(EGFR)、胰岛素样生长因子受体(IGFR)或胰岛素受体。在体外纯化EGFR的初步研究中,低剂量利多卡因增加EGFR酪氨酸激酶活性,高剂量利多卡因降低其活性。然而,在体内研究中,超过400μM的利多卡因抑制了egf刺激的人角膜上皮细胞的增殖,并抑制了egf刺激的EGFR自磷酸化。这些结果表明利多卡因通过直接抑制EGFR的酪氨酸激酶活性来抑制角膜上皮细胞的增殖。利多卡因抑制胰岛素刺激的胰岛素受体自磷酸化,并使已被胰岛素磷酸化的酪氨酸残基去磷酸化。在乳腺癌细胞系MCF-7中,IGFR对细胞增殖起重要作用,400μM以上的利多卡因抑制MCF-7的细胞增殖。我们认为利多卡因可能使IGFR去磷酸化,从而抑制MCF-7的增殖,而IGFR自磷酸化位点周围的氨基酸序列与胰岛素受体周围的氨基酸序列相同
英文摘要
Local anesthetics inhibit sodium channel through the direct effect on the inactivation gate. Head investigator revealed that amino-acid sequences around the autophosphorylation site at the activation loop of receptor-type tyrosine kinase surprisingly resemble to those around the inactivation gate of sodium channel, and started to investigate the effect of local anesthetics on the receptor-type tyrosine kinases. Under our hypothesis that local anesthetic, an amine having aromatic ring, would interact with aromatic, acidic, or basic amino acids through electrostatic, π-πstacking, cation-π, and C-H-π interactions, we studied the effect of lidocaine on autophosphorylation of receptor-type tyrosine kineses, such as epidermal growth factor receptor (EGFR), insulin-like growth factor receptor (IGFR), or insulin receptor.In the preliminary in vitro study using purified EGFR, low-dose lidocaine increased tyrosine kinase activity of EGFR, and high-dose lidocaine decreased it. In the in vivo study, however, over 400μM of lidocaine suppressed EGF-stimulated proliferation of human corneal epithelial cells, and inhibited EGF-stimulated autophosphorylation of EGFR. These results suggested that lidocaine suppresses corneal epithelial cell proliferation with direct inhibition of tyrosine kinase activity of EGFR. Lidocaine inhibited insulin-stimulated autophosphorylation of insulin receptor, and also dephosphorylated tyrosine residues already phosphorylated by insulin. In the breast cancer cell line, MCF-7, in which IGFR plays an important role for cell proliferation, over 400μM of lidocaine suppressed cell proliferation of MCF-7. We suggest that lidocaine might dephosphorylate IGFR, of which amino acid sequences around autophosphorylation site are the same as those around insulin receptor, and then suppressed MCF-7 proliferation
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Masashi Hirata: "Lidocaine inhibits tyrosine kinase activity of the epidermal growth factor receptor and suppreses proliferation of corneal epithelial cells."Anesthesiology. (印刷中). (2004)
Masashi Hirata:“利多卡因抑制表皮生长因子受体的酪氨酸激酶活性并抑制角膜上皮细胞的增殖。”麻醉学(2004 年出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Munetaka Hirose et al.: "Suppression of Insulin Signalling by a Synthetic Peptide KIFMK Suggests the Cytoplasmic Linker between DIII-56 and DIV-S1 as a Local Anaesthetic Binding Site on the Sodium Channel."British Journal of Pharmacology. (in press). (200
Munetaka Hirose 等人:“合成肽 KIFMK 对胰岛素信号传导的抑制表明 DIII-56 和 DIV-S1 之间的细胞质连接物是钠通道上的局麻药结合位点。”英国药理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Munetaka Hirose: "Mechanism of suppression of insulin signaling with lignocaine"British Journal of Phamacology. 136. 76-80 (2002)
Munetaka Hirose:“利多卡因抑制胰岛素信号传导的机制”英国药理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Munetaka Hirose et al.: "Mechanism of suppression of insulin signaling with lignocaine"British Journal of Pharmacology. 136. 76-80 (2002)
Munetaka Hirose 等人:“利多卡因抑制胰岛素信号传导的机制”英国药理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
平田昌史: "リドカインのヒト角膜上皮細胞増殖抑制作用の機序について"日本ペインクリニック学会誌. 9. 265 (2002)
Masashi Hirata:“利多卡因对人角膜上皮细胞增殖的抑制作用的机制”日本疼痛临床医师学会杂志 9. 265 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 10 条
Development of novel cell-penetrating peptides for treatment of cancer pain
-
批准号:22390297
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.15万
-
财政年份:2010
-
负责人:HIROSE Munetaka
-
依托单位:
Development of a cell-penetrating peptide, transported retrogradely in the axon, for treatment of uncontrolled pain
-
批准号:19390408
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.99万
-
财政年份:2007
-
负责人:HIROSE Munetaka
-
依托单位:
海外基金